Literature DB >> 17298957

The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study.

Jane S Saczynski1, Lon White, Rita L Peila, Beatriz L Rodriguez, Lenore J Launer.   

Abstract

The association between apolipoproteins and neurodegeneration is unclear. The authors examined the association of dementia with serum levels of apolipoprotein A-I (ApoA-I) alone and in combination with the apolipoprotein E genotype (ApoE). Subjects were Japanese-American men in Hawaii followed since 1965 in the Honolulu Heart Program cohort and the Honolulu-Asia Aging Study. Lipid levels were assessed in 1980-1982. Dementia was diagnosed in 1991-1993, 1994-1996, and 1997-1999 by using a multistep procedure and international guidelines. The sample consisted of 929 men (107 dementia cases). The relation between ApoA-I and dementia was examined by using Cox proportional hazards models adjusted for age, education, and cardiovascular risk factors. Compared with men in the lowest quartile, men in the highest quartile of ApoA-I concentration had a significantly lower risk of dementia (hazard ratio = 0.25, 95% confidence interval: 0.08, 0.78). Compared with men with both risk factors, those with a high ApoA-I concentration and no ApoE epsilon4 had a significantly lower risk of dementia (hazard ratio = 0.21, 95% confidence interval: 0.08, 0.52). Previous work has demonstrated an inverse relation between ApoA-I and cardiovascular disease, and the authors extended these findings to the risk of dementia. These results raise the possibility that different lipoprotein components of cholesterol may be differentially associated with dementia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298957     DOI: 10.1093/aje/kwm027

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  37 in total

Review 1.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

2.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

3.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

4.  Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study.

Authors:  Archana Singh-Manoux; David Gimeno; Mika Kivimaki; Eric Brunner; Michael G Marmot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-30       Impact factor: 8.311

5.  Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

Authors:  G Zuliani; M Cavalieri; M Galvani; S Volpato; A Cherubini; S Bandinelli; A M Corsi; F Lauretani; J M Guralnik; R Fellin; L Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-18       Impact factor: 6.053

6.  Is lipoprotein (a) protective of dementia?

Authors:  Setor K Kunutsor; Hassan Khan; Kristiina Nyyssönen; Jari A Laukkanen
Journal:  Eur J Epidemiol       Date:  2016-07-13       Impact factor: 8.082

Review 7.  Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration.

Authors:  Jeriel T R Keeney; Aaron M Swomley; Sarah Förster; Jessica L Harris; Rukhsana Sultana; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

8.  Estimating age-specific incidence of dementia using prevalent cohort data.

Authors:  Binbing Yu
Journal:  J Stat Comput Simul       Date:  2011-08       Impact factor: 1.424

9.  Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).

Authors:  Juho Tynkkynen; Jussi A Hernesniemi; Tiina Laatikainen; Aki S Havulinna; Jouko Sundvall; Jaana Leiviskä; Perttu Salo; Veikko Salomaa
Journal:  Age (Dordr)       Date:  2016-09-23

10.  Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Authors:  Alex E Roher; Chera L Maarouf; Lucia I Sue; Yiran Hu; Jeffrey Wilson; Thomas G Beach
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.